{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:35:36Z","timestamp":1790163336923,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.biopsych.2011.07.035","type":"journal-article","created":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T15:31:08Z","timestamp":1317051068000},"page":"1006-1014","source":"Crossref","is-referenced-by-count":111,"title":["N-Acetylcysteine Normalizes Neurochemical Changes in the Glutathione-Deficient Schizophrenia Mouse Model During Development"],"prefix":"10.1016","volume":"71","author":[{"given":"Joao Miguel","family":"das Neves Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Kulak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi Mohammad","family":"Gholam-Razaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Cuenod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Gruetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Quang","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"R1","key":"10.1016\/j.biopsych.2011.07.035_bib1","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddq167","article-title":"Parkinson's disease: Insights from pathways","volume":"19","author":"Cookson","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2011.07.035_bib2","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease","volume":"16","author":"Agostinho","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biopsych.2011.07.035_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10863-010-9290-y","article-title":"Mitochondrial matters of the brain: The role in Huntington's disease","volume":"42","author":"Turner","year":"2010","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.biopsych.2011.07.035_bib4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s11064-010-0195-2","article-title":"Role of oxidative stress in the pathophysiology of bipolar disorder","volume":"35","author":"Steckert","year":"2010","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2011.07.035_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.conb.2009.05.001","article-title":"Redox dysregulation, neurodevelopment, and schizophrenia","volume":"19","author":"Do","year":"2009","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.biopsych.2011.07.035_bib6","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2011.07.035_bib7","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1089\/ars.2010.3453","article-title":"Magnetic resonance spectroscopy studies of the antioxidant system in schizophrenia","volume":"15","author":"Matsuzawa","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.biopsych.2011.07.035_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"Yao","year":"2006","journal-title":"Dis Markers"},{"key":"10.1016\/j.biopsych.2011.07.035_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/507566","article-title":"Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene","volume":"79","author":"Tosic","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2011.07.035_bib10","doi-asserted-by":"crossref","first-page":"16621","DOI":"10.1073\/pnas.0706778104","article-title":"Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence","volume":"104","author":"Gysin","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2011.07.035_bib11","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1089\/ars.2010.3646","article-title":"Oxidative stress in schizophrenia: Pathogenetic and therapeutic implications","volume":"15","author":"Yao","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.biopsych.2011.07.035_bib12","doi-asserted-by":"crossref","first-page":"49446","DOI":"10.1074\/jbc.M209372200","article-title":"Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(\u2212\/\u2212) knockout mouse: Novel model system for a severely compromised oxidative stress response","volume":"277","author":"Yang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2011.07.035_bib13","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1523\/JNEUROSCI.3857-09.2010","article-title":"Redox dysregulation affects the ventral but not dorsal hippocampus: Impairment of parvalbumin neurons, gamma oscillation, and related behaviours","volume":"30","author":"Steullet","year":"2010","journal-title":"J Neurosci"},{"issue":"suppl","key":"10.1016\/j.biopsych.2011.07.035_bib14","first-page":"199","article-title":"Reverse translational approach to redox dysregulation in schizophrenia: Genetics, environment, neurodevelopment and therapy","volume":"67","author":"Do","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib15","unstructured":"Monin A, Klaey M, Butticaz C, Cabungcal JH, Steullet P, Do KQ (2011): Redox dysregulation affects proliferation, differentiation of oligodendrocyte progenitors and myelination: Relevance for Schizophrenia Abstract at the Viewer\/Itinerary Planner, 41th Annual Meeting of the Society for Neuroscience, Washington, DC."},{"key":"10.1016\/j.biopsych.2011.07.035_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.neuro.25.112701.142754","article-title":"Schizophrenia as a disorder of neurodevelopment","volume":"25","author":"Lewis","year":"2002","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.biopsych.2011.07.035_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijdevneu.2010.10.003","article-title":"Childhood onset schizophrenia: Support for a progressive neurodevelopmental disorder","volume":"29","author":"Rapoport","year":"2010","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.biopsych.2011.07.035_bib18","first-page":"1949","article-title":"Measurements of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: A systematic review and methanalysis","volume":"30","author":"Steen","year":"2005","journal-title":"Neuropsychology"},{"key":"10.1016\/j.biopsych.2011.07.035_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroimage.2010.06.006","article-title":"Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: A combined MRI and 1H-MRS study","volume":"53","author":"Kl\u00e4r","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2011.07.035_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.eurpsy.2009.10.001","article-title":"Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls","volume":"26","author":"Goto","year":"2011","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2009.08.012","article-title":"Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: A (1)H spectroscopy study","volume":"115","author":"Keshavan","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2011.07.035_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.schres.2009.03.036","article-title":"Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: Investigation of anterior cingulated, dorsolateral prefrontal cortex and thalamus","volume":"111","author":"Yoo","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2011.07.035_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/mp.2009.121","article-title":"1H-MRS at 4 Tesla in minimally treated early schizophrenia","volume":"15","author":"Bustillo","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/mp.2008.87","article-title":"Proton MRS in twin pairs discordant for schizophrenia","volume":"15","author":"Lutkenhoff","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib25","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1176\/appi.ajp.161.6.1116","article-title":"3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia","volume":"161","author":"Tibbo","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-244X-5-6","article-title":"Elevated glutamine\/glutamate ratio in cerebrospinal fluid of first episode and drug na\u00efve schizophrenic patients","volume":"5","author":"Hashimoto","year":"2005","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib27","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/npp.2011.65","article-title":"Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis","volume":"36","author":"de la Fuente-Sandoval","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2011.07.035_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2008.11.014","article-title":"Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)","volume":"108","author":"Tayoshi","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2011.07.035_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2004.08.021","article-title":"Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not first-episode patients with schizophrenia: A proton magnetic resonance spectroscopy study","volume":"73","author":"Ohrmann","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2011.07.035_bib30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/nbm.1385","article-title":"Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: An in vivo localized 1H MRS study","volume":"22","author":"Iltis","year":"2009","journal-title":"NMR Biomed"},{"key":"10.1016\/j.biopsych.2011.07.035_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans, Psychomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3371\/CSRP.4.3.6","article-title":"Thinking glutamatergically: Changing concepts of schizophrenia based upon changing neurochemical models","volume":"4","author":"Kantrowitz","year":"2010","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"10.1016\/j.biopsych.2011.07.035_bib33","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/j.1471-4159.2010.07051.x","article-title":"Neurochemical profile of the developing mouse cortex determined by in vivo 1H NMR spectroscopy at 14 T and the effect of recurrent anesthaesia","volume":"115","author":"Kulak","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2011.07.035_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine\u2014A safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.biopsych.2011.07.035_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0076-6879(95)52005-8","article-title":"Glutathione biosynthesis and its inhibition","volume":"252","author":"Meister","year":"1995","journal-title":"Methods Enzymol"},{"issue":"29","key":"10.1016\/j.biopsych.2011.07.035_bib36","doi-asserted-by":"crossref","first-page":"22244","DOI":"10.1074\/jbc.M110.121327","article-title":"System x(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency","volume":"285","author":"Mandal","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2011.07.035_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia\u2014a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib38","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/sj.npp.1301624","article-title":"Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients","volume":"33","author":"Lavoie","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2011.07.035_bib39","series-title":"The Handbook of Experimental Animals: The Laboratory Mouse","author":"Hedrich","year":"2008"},{"key":"10.1016\/j.biopsych.2011.07.035_bib40","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/mrm.21961","article-title":"MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T","volume":"61","author":"Mekle","year":"2009","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.biopsych.2011.07.035_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10334-008-0152-0","article-title":"In vivo measurement of glycine with short echo-time 1H MRS in human brain at 7 T","volume":"22","author":"Gambarota","year":"2008","journal-title":"MAGMA"},{"key":"10.1016\/j.biopsych.2011.07.035_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/jmre.1999.1895","article-title":"Toward an in vivo neurochemical profile: Quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain","volume":"141","author":"Pfeuffer","year":"1999","journal-title":"J Magn Reson"},{"key":"10.1016\/j.biopsych.2011.07.035_bib43","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/mrm.1910290613","article-title":"Automatic, localized in vivo adjustment of all first- and second-order shim coils","volume":"29","author":"Gruetter","year":"1993","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.biopsych.2011.07.035_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1","article-title":"Field mapping without reference scan using asymmetric echo-planar techniques","volume":"43","author":"Gruetter","year":"2000","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.biopsych.2011.07.035_bib45","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/mrm.21043","article-title":"Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition","volume":"56","author":"Mlyn\u00e1rik","year":"2006","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.biopsych.2011.07.035_bib46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/A:1020884312053","article-title":"Food intake, water intake, and drinking spout side preference of 28 mouse strains","volume":"32","author":"Bachmanov","year":"2002","journal-title":"Behav Genet"},{"key":"10.1016\/j.biopsych.2011.07.035_bib47","series-title":"Introduction to Linear Regression Analysis","author":"Montgomery","year":"2006"},{"key":"10.1016\/j.biopsych.2011.07.035_bib48","series-title":"Abstract 225.6 Viewer\/Itinerary Planner","article-title":"Glutathione un-GLU-ed: A role for glutathione in neuronal glutamate metabolism","author":"Koga","year":"2010"},{"key":"10.1016\/j.biopsych.2011.07.035_bib49","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s11033-010-9998-0","article-title":"Protection by pyruvate against glutamate neurotoxicity is mediated by astrocytes through glutathione-dependent mechanism","volume":"38","author":"Miao","year":"2010","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.biopsych.2011.07.035_bib50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuint.2005.12.021","article-title":"Glutamate, a neurotransmitter\u2014and so much more","volume":"48","author":"Hertz","year":"2006","journal-title":"Neurochem Int"},{"key":"10.1016\/j.biopsych.2011.07.035_bib51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainresbull.2010.04.006","article-title":"N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?","volume":"83","author":"Kantrowitz","year":"2010","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2011.07.035_bib52","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J Neurosci"},{"issue":"suppl 1","key":"10.1016\/j.biopsych.2011.07.035_bib53","first-page":"102","article-title":"Redox dysregulation and oxidative stress affect parvalbumin interneurons and neural synchrony in anterior cingulated cortex during neurodevelopment","volume":"37","author":"Cuenod","year":"2011","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2011.07.035_bib54","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2011.07.035_bib55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.biopsych.2008.06.011","article-title":"Capitalizing on extrasynaptic glutamate neurotransmission to treat antipsychotic-resistant symptoms in schizophrenia [review]","volume":"64","author":"Krystal","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib56","unstructured":"Torres GE, Pena K, Quiroz M, Amara SG, Underhill SM (2010): Functional coupling between the glutamate transporter EAAT2 and glutamine synthetase. Abstract 544.13 Viewer\/Itinerary Planner, 40th Annual Meeting of the Society for Neuroscience, San Diego, California."},{"key":"10.1016\/j.biopsych.2011.07.035_bib57","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/BF02533072","article-title":"Biosynthesis of brain sphingolipids and myelin accumulation in the mouse","volume":"7","author":"Costantino-Ceccarini","year":"1972","journal-title":"Lipids"},{"key":"10.1016\/j.biopsych.2011.07.035_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1471-4159.2001.00015.x","article-title":"Parameters related to lipid metabolism as markers of myelination in mouse brain","volume":"76","author":"Muse","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2011.07.035_bib59","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0169-328X(02)00490-4","article-title":"Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: Therapeutic implications for Canavan disease","volume":"107","author":"Kirmani","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.biopsych.2011.07.035_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/neuro.05.009.2009","article-title":"Linking white and grey matter in schizophrenia: Oligodendrocyte and neuron pathology in the prefrontal cortex","volume":"3","author":"H\u00f6istad","year":"2009","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.biopsych.2011.07.035_bib61","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.170209797","article-title":"Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell","volume":"97","author":"Smith","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2011.07.035_bib62","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0006-3223(02)01397-5","article-title":"Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites","volume":"52","author":"Yao","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib63","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archpsyc.1991.01810300075011","article-title":"Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-na\u00efve schizophrenics: A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy","volume":"48","author":"Pettegrew","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.biopsych.2010.08.024","article-title":"Glutamate as a marker of cognitive function in schizophrenia: A proton spectroscopic imaging study at 4 Tesla","volume":"69","author":"Bustillo","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib65","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1006\/nimg.2002.1254","article-title":"Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-na\u00efve HIV patients","volume":"17","author":"Chang","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2011.07.035_bib66","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archneur.59.6.955","article-title":"Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease","volume":"59","author":"Chantal","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2011.07.035_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0047-6374(97)01877-0","article-title":"Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging","volume":"97","author":"Parnetti","year":"1997","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.biopsych.2011.07.035_bib68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/10715762.2010.534163","article-title":"\u03b1-ketoglutarate dehydrogenase: A mitochondrial redox sensor","volume":"45","author":"McLain","year":"2011","journal-title":"Free Radic Res"},{"key":"10.1016\/j.biopsych.2011.07.035_bib69","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jneumeth.2007.11.017","article-title":"Increased lactate levels and reduced pH in postmortem brains of schizophrenics: Medication confounds","volume":"169","author":"Halim","year":"2008","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.biopsych.2011.07.035_bib70","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.schres.2009.01.017","article-title":"Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia","volume":"109","author":"Beasley","year":"2009","journal-title":"Schizo Res"},{"key":"10.1016\/j.biopsych.2011.07.035_bib71","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001532","article-title":"Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib72","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.biopsych.2008.11.010","article-title":"Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: Implications for the mitochondrial dysfunction hypothesis","volume":"65","author":"Regenold","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.07.035_bib73","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1371\/journal.pmed.0030327","article-title":"Metabolic profiling of CSF: Evidence that early intervention may impact on disease progression and outcome in schizophrenia","volume":"3","author":"Holmes","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.biopsych.2011.07.035_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.psychres.2010.02.014","article-title":"Plasma alanine levels increase in patients with schizophrenia as their clinical symptoms improve-Results from the Juntendo University Schizophrenia Projects (JUSP)","volume":"177","author":"Hatano","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2011.07.035_bib75","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.earlhumdev.2005.10.013","article-title":"Ontogeny of the human nervous system: What is happening when?","volume":"82","author":"De Graaf-Peters","year":"2006","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.biopsych.2011.07.035_bib76","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1046\/j.1471-4159.2003.01580.x","article-title":"The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice","volume":"84","author":"Farr","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2011.07.035_bib77","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/hipo.20421","article-title":"Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation","volume":"18","author":"Lant\u00e9","year":"2008","journal-title":"Hippocampus"},{"key":"10.1016\/j.biopsych.2011.07.035_bib78","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.mrrev.2003.05.004","article-title":"Birth-related genomic and transcriptional changes in mouse lung modulation by transplacental N-acetylcysteine","volume":"544","author":"Izzotti","year":"2003","journal-title":"Mutat Res"},{"key":"10.1016\/j.biopsych.2011.07.035_bib79","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0378-1097(03)00611-6","article-title":"Taurine: New implications for an old amino acid","volume":"226","author":"Schuller-Levis","year":"2003","journal-title":"FEMS Microbiol Lett"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322311007827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322311007827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T21:00:13Z","timestamp":1543525213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322311007827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0006322311007827"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2011.07.035","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}